EVOK - Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2021 Results - Earnings Call Transcript

Evoke Pharma, Inc. (EVOK) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Daniel Kontoh-Boateng – Investor Relations Dave Gonyer – Chief Executive Officer Matt D'Onofrio – Chief Business Officer Chris Quesenberry – Chief Commercial Officer-GIMOTI, EVERSANA Conference Call Participants Mitchell Kapoor – H.C. Wainwright Yale Jen – Laidlaw and Company Presentation Daniel Kontoh-Boateng Good afternoon and welcome to Evoke Pharma's Third Quarter 2021 Earnings Conference Call and Audio Webcast. With me today are Dave Gonyer, Evoke's Chief Executive Officer; and Matt D'Onofrio, Chief Business Officer; as well as Chris Quesenberry, GIMOTI's Chief Commercial Officer from EVERSANA. Earlier today, Evoke issued a press release announcing financial results for the third quarter that September 30, 2021. We encourage everyone to read today's press release as well as Evoke's quarterly report on Form 10-Q, which is filed with the SEC. The Company's 10-Q report and press release are

For further details see:

Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2021 Results - Earnings Call Transcript